This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Behavioural Health Remove Development Remove Regulation Related Topics
Pharma Companies Pharmacy Doctors Trials Life Science Research Clinical Trials Medicine Marketing Business Development More Related Topics >
article thumbnail

Cognoa preps FDA filing for digital autism diagnostic

pharmaphorum

SEPTEMBER 24, 2020

An artificial intelligence-powered diagnostic for autism spectrum disorder (ASD), developed by Cognoa, has met all its objectives in a pivotal trial and will be filed for approval with the FDA. It’s reported that parents can often spot the early signs of developmental problems within 18 months.

Behavioural Health 104
Behavioural Health Doctors Doctor Development 104
article thumbnail

What we’re expecting in 2021, and beyond…

pharmaphorum

JANUARY 26, 2021

There is an opportunity to address this at scale with digital tools and techniques, and expand support into just about any therapeutic area through the holistic integration of mental and behavioural health solutions that improve patient care. Services to manage and make sense of the health data explosion.

Clinical Trials 129
Clinical Trials Clinical Trials Sales Life Science 129
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024